🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark Jesus M. Magbanua

University of California, San Francisco

ORCID: 0000-0003-2113-3593

Also affiliated with University of San Francisco

Biochemistry, Genetics and Molecular BiologyMedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
4.9Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Cancer Cell(2022)10.1016/j.ccell.2022.05.005
Top 4%
4.9DataRank
Top 4%329 citations

Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee +28 more

Papers

Driven by 19 papers — median percentile 96. Top paper: “Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies”.

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Cancer Cell(2022)10.1016/j.ccell.2022.05.005
Top 4%
4.9DataRank
Top 4%329 citations

Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee +28 more

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

Cancer Cell(2023)10.1016/j.ccell.2023.04.008
N/A
0.777DataRank · unranked
177 citations

Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W. Sayaman, Derrick Renner, Ekaterina Kalashnikova +26 more

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk

npj Breast Cancer(2021)10.1038/s41523-021-00239-3
N/A
0.598DataRank · unranked
53 citations

Wen Li, Denise M. Wolf, Christina Yau, Gillian L. Hirst, Lamorna Brown Swigart +12 more

Implantation of engineered adipocytes suppresses tumor progression in cancer models

Nature Biotechnology(2025)10.1038/s41587-024-02551-2
N/A
0.550DataRank · unranked
38 citations

Kelly An, Yusuke Ito, Bhushan N. Kharbikar, Rory R Sheng, Beatriz Paredes +23 more

Clinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1329
N/A
0.483DataRank · unranked
24 citations

Oleksandr Savenkov, Erik Asmus, Karla V. Ballman, Janet H. Scott, John W. Park +6 more

Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101312
N/A
0.442DataRank · unranked
18 citations

Julia Wulfkuhle, Denise M. Wolf, Lamorna Brown Swigart, Christina Yau, Nicholas O’Grady +22 more

Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502

npj Breast Cancer(2024)10.1038/s41523-024-00683-x
N/A
0.419DataRank · unranked
7 citations

Roberto Salgado, Oleksander Savenkov, Karla V. Ballman, Erica L. Mayer, Mark Jesus M. Magbanua +11 more

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors

Nature Communications(2025)10.1038/s41467-025-65432-5
N/A
0.292DataRank · unranked
6 citations

Nayelis A. Manon, Denise M. Wolf, Samuel Rivero-Hinojosa, Ziad Ahmed, Rosalyn W. Sayaman +20 more

Association of tumor infiltrating lymphocyte quantity with survival in patients (pts) with metastatic breast cancer (MBC) receiving microtubule-targeting agents: Post hoc analysis CALGB 40502 (Alliance).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1010
N/A
0.203DataRank · unranked
2 citations

Roberto Salgado, Oleksandr Savenkov, Karla V. Ballman, Mark Jesus M. Magbanua, Sherene Loi +11 more

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

Annals of Oncology(2020)10.1016/j.annonc.2020.11.007
N/A
0DataRank · unranked
445 citations

Lamorna Brown Swigart, H.-T. Wu, Gillian L. Hirst, Christina Yau, Denise M. Wolf +19 more

MRI-Based Model for Personalizing Neoadjuvant Treatment in Breast Cancer

Tomography(2025)10.3390/tomography11030026
N/A
0DataRank · unranked
4 citations

Natsuko Onishi, Jessica Gibbs, Lisa J. Wilmes, Nu N. Le, Pouya Metanat +12 more

Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa113
N/A
0DataRank · unranked
48 citations

Laura H. Hendrix, Terry Hyslop, William T. Barry, Eric P. Winer, Clifford A. Hudis +27 more

Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival

medRxiv(2020)10.1101/2020.02.03.20019760
N/A
0DataRank · unranked
41 citations

Lamorna Brown Swigart, Hsin-Ta Wu, Gillian L. Hirst, Christina Yau, Denise M. Wolf +18 more

Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy

Cancers(2022)10.3390/cancers14184436
N/A
0DataRank · unranked
23 citations

Nu N. Le, Natsuko Onishi, David C. Newitt, Lisa J. Wilmes, Jessica Gibbs +15 more

Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy

Frontiers in Oncology(2022)10.3389/fonc.2022.802579
N/A
0DataRank · unranked
16 citations

Özge Gümüşay, Razelle Kurzrock, L. J. van ‘t Veer, Hope S. Rugo, Mark Jesus M. Magbanua

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance

Molecular Cancer(2023)10.1186/s12943-022-01710-w
N/A
0DataRank · unranked
270 citations

Hani Goodarzi, Josef Srovnal, Marián Hajdúch, L. J. van ‘t Veer, Mark Jesus M. Magbanua +1 more

Implantation of engineered adipocytes that outcompete tumors for resources suppresses cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.28.534564
N/A
0DataRank · unranked
3 citations

Rory Sheng, Elizabeth Murray, Yusuke Ito, Michael Brück, Cassidy Biellak +10 more

Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2928
N/A
0DataRank · unranked
13 citations

Ziad Ahmed, Rosalyn W. Sayaman, Lamorna Brown Swigart, Gillian L. Hirst, Christina Yau +13 more

Autophagy-targeted NBR1–p62/SQSTM1 complexes promote breast cancer metastasis by sequestering ITCH

Nature Cell Biology(2025)10.1038/s41556-025-01689-8
N/A
0DataRank · unranked
13 citations

Hugo González, Timothy Marsh, Andrew M. Leidal, Ariadne Vlahakis, Pravin R. Phadatare +10 more